Management of Gastrointestinal Disorders in the Bariatric Patient

Medical Clinics of North America

Volumn 91, Issue 3, 2007, Pages 443-450

  Markel, Troy A ^a   Mattar, Samer G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; URSODEOXYCHOLIC ACID;

BARIATRIC SURGERY; CHOLECYSTECTOMY; CHOLECYSTITIS; CLINICAL TRIAL; DIETARY INTAKE; EXERCISE; GALLSTONE FORMATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; MEDICAL INFORMATION; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT COUNSELING; PHYSICIAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; STOMACH SURGERY; WEIGHT REDUCTION;

CHOLECYSTITIS; FATTY LIVER; GASTRIC BYPASS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HUMANS; OBESITY, MORBID; POSTOPERATIVE CARE; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 34248155144     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.01.004     Document Type: Review

References (38)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
2. Luyckx F.H., Desaive C., Thiry A., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 22 (1998) 222-226
3. Franzese A., Vajro P., Argenziano A., et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42 (1997) 1428-1432
4. Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30 (1999) 1356-1362
5. Sabir N., Sermez Y., Kazil S., et al. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound 14 (2001) 121-128
6. Scheen A.J., and Luyckx F.H. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 16 (2002) 703-716
7. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132 (2000) 112-117
8. Yu A.S., and Keeffe E.B. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2 (2002) 11-19
9. Hui J.M., Kench J.G., Chitturi S., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 (2003) 420-427
10. Ratziu V., Bonyhay L., Di Martino V., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 35 (2002) 1485-1493
11. Mottin C.C., Moretto M., Padoin A.V., et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 15 (2005) 788-793
12. Mattar S.G., Velcu L.M., Rabinovitz M., et al. Surgically induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242 (2005) 610-617 [discussion: 618-20]
13. de Almeida S.R., Rocha P.R., Sanches M.D., et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg 16 (2006) 270-278
14. Barker K.B., Palekar N.A., Bowers S.P., et al. Nonalcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol 101 (2006) 368-373
15. Dixon J.B., Bhathal P.S., Hughes N.R., et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654
16. Cobb W.S., Heniford B.T., Burns J.M., et al. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc 19 (2005) 418-423
17. Dallal R.M., Mattar S.G., Lord J.L., et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 14 (2004) 47-53
18. Tichansky D.S., and Madan A.K. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg 15 (2005) 1481-1486
19. Duchini A., and Brunson M.E. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation 72 (2001) 156-159
20. Guadalajara H., Sanz Baro R., Pascual I., et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass?. Obes Surg 16 (2006) 883-885
21. Vanek V.W., Catania M., Triveri K., et al. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. Surg Obes Relat Dis 2 (2006) 17-22 [discussion: 22-3]
22. Swartz D.E., and Felix E.L. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?. Surg Obes Relat Dis 1 (2005) 555-560
23. Liem R.K., and Niloff P.H. Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 14 (2004) 763-765
24. Taylor J., Leitman I.M., and Horowitz M. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass?. Obes Surg 16 (2006) 759-761
25. Caruana J.A., McCabe M.N., Smith A.D., et al. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?. Surg Obes Relat Dis 1 (2005) 564-567 [discussion: 567-8]
26. Papasavas P.K., Gagne D.J., Ceppa F.A., et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2 (2006) 41-46 [discussion: 46-7]
27. Scott D.J., Villegas L., Sims T.L., et al. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc 17 (2003) 1796-1802
28. Wudel Jr. L.J., Wright J.K., Debelak J.P., et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 102 (2002) 50-56
29. Corley D.A., and Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 101 11 (2006) 2619-2628
30. Kostikas K., Papaioannou A.I., and Gourgoulianis K.I. BMI and gastroesophageal reflux in women. N Engl J Med 355 (2006) 848 [author reply: 849-50]
31. Csendes A., Burgos A.M., Smok G., et al. Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg 10 (2006) 259-264
32. Nelson L.G., Gonzalez R., Haines K., et al. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg 71 (2005) 950-953 [discussion: 953-4]
33. Raftopoulos I., Awais O., Courcoulas A.P., et al. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg 14 (2004) 1373-1380
34. Mattar S.G., Qureshi F., Taylor D., et al. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 20 (2006) 850-854
35. Spivak H., Hewitt M.F., Onn A., et al. Weight loss and improvement of obesity-related illness in 500 US patients following laparoscopic adjustable gastric banding procedure. Am J Surg 189 (2005) 27-32
36. Suter M., Dorta G., Giusti V., et al. Gastric banding interferes with esophageal motility and gastroesophageal reflux. Arch Surg 140 (2005) 639-643
37. Gutschow C.A., Collet P., Prenzel K., et al. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg 9 (2005) 941-948
38. de Jong J.R., van Ramshorst B., Timmer R., et al. Effect of laparoscopic gastric banding on esophageal motility. Obes Surg 16 (2006) 52-58